In summary, a thorough investigation into the role of the mtDNA-cGAS-STING pathway in AD is crucial for understanding its pathogenesis, identifying new therapeutic targets, and providing more possibilities for alleviating symptoms and slowing disease progression in patients with AD. The gene discussed is CGAS; the disease is Alzheimer disease.